VERSATILITY IN LIPID COMPOSITIONS SHOWING PROLONGED CIRCULATION WITH STERICALLY STABILIZED LIPOSOMES

被引:202
作者
WOODLE, MC
MATTHAY, KK
NEWMAN, MS
HIDAYAT, JE
COLLINS, LR
REDEMANN, C
MARTIN, FJ
PAPAHADJOPOULOS, D
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,CANC RES INST,SAN FRANCISCO,CA 94143
关键词
LIPOSOME; CLEARANCE; POLY(ETHYLENE GLYCOL); DESFEROXAMINE; GA-67; (MOUSE); (RAT);
D O I
10.1016/0005-2736(92)90194-Q
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Efforts to overcome rapid uptake of liposomes by cells of the mononuclear phagocytic system (MPS) have identified that lipids derivatized with the hydrophilic polymer poly(ethylene glycol) (PEG) have many advantages. The structure-function relationship of PEG-derivatized phosphatidylethanolamine (PEG-PE) has been examined by studies of blood lifetime and tissue distribution in both mice and rats. Liposomes composed of phosphatidylcholine (PC), cholesterol, and 7.5 mol% of PEG-PE show prolonged circulation and reduced MPS uptake when the PEG has a molecular weight in the range of 1000 to 5000. Up to 35% of the injected dose remains in the blood and less than 10% is taken up by the MPS (liver plus spleen) after 24 h in the best cases as compared to 1% and 40%, respectively, for liposomes without PEG-PE. Prolonged circulation with PEG-PE is independent of cholesterol, degree of saturation in either the PC or the PE lipid anchor, lipid dose, or addition of other negatively charged lipids. phosphatidylglycerol or cholesterol sulfate. This versatility in lipid composition and dose without alteration of blood lifetime or tissue distribution is essential for controlling drug dosage and release properties in a liposome-based therapeutic agent.
引用
收藏
页码:193 / 200
页数:8
相关论文
共 31 条
[1]  
ALLEN T M, 1989, P405
[2]   LIPOSOMES WITH PROLONGED CIRCULATION TIMES - FACTORS AFFECTING UPTAKE BY RETICULOENDOTHELIAL AND OTHER TISSUES [J].
ALLEN, TM ;
HANSEN, C ;
RUTLEDGE, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 981 (01) :27-35
[3]   LARGE UNILAMELLAR LIPOSOMES WITH LOW UPTAKE INTO THE RETICULOENDOTHELIAL SYSTEM [J].
ALLEN, TM ;
CHONN, A .
FEBS LETTERS, 1987, 223 (01) :42-46
[4]  
[Anonymous], 1988, LIPOSOMES DRUG CARRI
[5]   LIPOSOMES FOR THE SUSTAINED DRUG RELEASE INVIVO [J].
BLUME, G ;
CEVC, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1029 (01) :91-97
[7]  
GABIZON A, 1990, CANCER RES, V50, P6371
[8]   THE ROLE OF SURFACE-CHARGE AND HYDROPHILIC GROUPS ON LIPOSOME CLEARANCE INVIVO [J].
GABIZON, A ;
PAPAHADJOPOULOS, D .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1103 (01) :94-100
[9]   PHARMACOKINETICS AND TISSUE DISTRIBUTION OF DOXORUBICIN ENCAPSULATED IN STABLE LIPOSOMES WITH LONG CIRCULATION TIMES [J].
GABIZON, A ;
SHIOTA, R ;
PAPAHADJOPOULOS, D .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (19) :1484-1488
[10]  
GABIZON A, 1988, P NATL ACAD SCI USA, V85, P5949